News

May 23, 2018May 23, 2018

TapImmune and Marker Moving Ahead on Merger with Goal of Creating New Immuno-Oncology Platform

News

TapImmune announced it has entered into a definitive merger agreement with Marker Therapeutics, bringing that company’s multi-antigen T-cell therapy platform to its peptide vaccine portfolio. Markers’ platform has shown promis in ... Read more

May 22, 2018May 22, 2018

Adcetris-Dacarbazine Combo is Effective in Elderly Hodgkin’s Patients, Study Finds

News

A combination of Adcetris (brentuximab vedotin) and dacarbazine chemotherapy may be a suitable option for frail, elderly patients with classical Hodgkin’s lymphoma who are ineligible for standard treatment, according to data ... Read more

May 21, 2018

Arranon Add-on Improves Long-term Outcomes in Young Patients with T-cell Cancers, Trial Shows

News

A combination of Arranon (nelarabine) and standard chemotherapy led to the highest survival rates seen to date in children and young adults with T-cell acute lymphoblastic leukemia (T-ALL), a Phase ... Read more

May 18, 2018May 18, 2018

1st Mantle Cell Lymphoma Patient Dosed in Phase 1/2 Trial Testing Cirmtuzumab-Imbruvica Combo

News

A Phase 1b/2 clinical trial evaluating Oncternal Therapeutics‘ investigational therapy cirmtuzumab in combination with Imbruvica (ibrutinib) for the treatment of B-cell malignancies has dosed its first patient with mantle cell lymphoma. The trial is ... Read more

May 16, 2018

‘Social Network’ of Genes May Help Identify New Therapy Targets for Lymphoma, Other Cancers

News

Understanding the ‘social network’ of genes — how they interact with each other — may help scientists in both normal conditions and in diseases like cancer. Researchers developed a new ... Read more

May 15, 2018

Young Cancer Survivors Show Signs of Accelerated Aging, Study Finds

News

Adolescents and young adults who survive cancer are at higher risk of mental and physical weakness and of developing age-related diseases, such as depression and anxiety, a study reports. Other ... Read more

May 14, 2018

Zevalin Plus Aggressive Chemotherapy Safe, Effective for Follicular Lymphoma, Phase 2 Trial Shows

News

Supplementing an aggressive chemotherapy regimen with Zevalin (ibritumomab tiuxetan) is safe and provides improved clinical response in patients with intermediate or high-risk follicular lymphoma, results from a Phase 2 clinical trial show. ... Read more

May 11, 2018

Bowel Rest Not Seen to Benefit NHL Patients with Gastrointestinal Involvement in Study

News

Bowel rest — in which patients do not ingest any food and are fed intravenously — does not significantly lower perforation rates or improve overall outcomes in non-Hodgkin’s lymphoma patients with ... Read more

May 10, 2018

UK Agency Recommends 3 New Blood Cancer Therapies, Including Adcetris for Lymphoma

News

The United Kingdom’s National Institute for Health and Care Excellence (NICE) recently recommended that three new blood cancer therapies be covered by the National Health Service (NHS) — Trisenox (arsenic trioxide), Rydapt ... Read more

May 9, 2018May 9, 2018

Gift of Life Marrow Registry Helps California Dad with Leukemia

News

The nonprofit Gift of Life Marrow Registry recently helped a California father of three get a second chance at life, after matching a donor nearly 3,000 miles away in New ... Read more